Zepp Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	69.66	57.05	91.07	133.67	128.55	231.17
Short-Term Investments	-	-	1	5.15	4.98	3.83
Cash & Short-Term Investments	69.66	57.05	92.07	138.82	133.52	235
Cash Growth	23.38%	-38.04%	-33.68%	3.97%	-43.18%	-33.20%
Accounts Receivable	82.59	73.57	65.63	69.33	116.33	129.99
Other Receivables	-	24.03	13.52	12.63	8.35	41.27
Receivables	82.59	97.6	79.15	81.96	126.18	171.26
Inventory	62.43	72.76	56.79	84.89	148.16	196.66
Prepaid Expenses	31.22	8.67	3.66	4.03	7.78	8.05
Restricted Cash	36.61	55.89	19.67	6.8	12.57	6.46
Other Current Assets	-	1.56	0.24	0.24	0.72	1.36
Total Current Assets	282.51	293.53	251.56	316.73	428.95	618.79
Property, Plant & Equipment	7.58	7.62	10.36	15.75	24.09	38.14
Long-Term Investments	227.82	220.05	225.91	238.54	244.54	244.4
Goodwill	9.58	9.58	9.58	9.58	9.58	9.61
Other Intangible Assets	12.81	13.61	7.09	9.87	17.88	21.34
Long-Term Deferred Tax Assets	16.02	15.74	17.47	32.4	30.47	22.58
Other Long-Term Assets	3.35	3.72	4.61	9.7	7.31	3.08
Total Assets	559.67	564.84	528.59	635.52	763.74	957.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	199.65	192.79	114.56	106.15	138.03	231.27
Accrued Expenses	37.18	7.93	7.94	8.06	8.69	14.14
Short-Term Debt	76.84	55.73	41.85	1.69	74.23	56.35
Current Portion of Leases	-	0.93	1.36	3.87	6.14	7.89
Current Income Taxes Payable	0.25	0.37	0.51	0.99	0.39	0.41
Current Unearned Revenue	-	27.88	27.02	30.42	9.12	14.34
Other Current Liabilities	0.45	1.22	2.13	3.93	5.33	14.38
Total Current Liabilities	314.38	286.84	195.37	155.11	241.93	338.78
Long-Term Debt	56.4	59.48	75.24	120.02	99.2	114.42
Long-Term Leases	1.07	1.1	2.01	3.2	4.59	11.19
Long-Term Unearned Revenue	0.11	0.21	0.13	0.27	23.58	27.56
Long-Term Deferred Tax Liabilities	2.75	2.67	3.12	4.17	5.15	4.24
Total Liabilities	374.7	350.3	275.87	282.77	374.46	496.18

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.03	0.02	0.03
Additional Paid-In Capital	282.33	280.68	278.12	273.39	245.15	258.41
Retained Earnings	-42.42	-11.45	28.62	104.35	136.7	200.1
Treasury Stock	-17.57	-16.15	-14.99	-12.87	-9.74	-3.43
Comprehensive Income & Other	-37.39	-38.57	-40.18	-14.01	15.34	4.61
Total Common Equity	184.97	214.53	251.59	350.88	387.48	459.71
Minority Interest	-	-	1.14	1.87	1.8	2.06
Shareholders' Equity	184.97	214.53	252.73	352.75	389.28	461.77
Total Liabilities & Equity	559.67	564.84	528.59	635.52	763.74	957.95

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	134.31	117.24	120.46	128.78	184.16	189.85
Net Cash (Debt)	-64.64	-60.19	-28.39	10.04	-50.64	45.15
Net Cash Growth	-	-	-	-	-	-81.20%
Net Cash Per Share	-4.08	-3.79	-1.75	0.66	-3.29	2.73
Filing Date Shares Outstanding	15.83	14.66	14.37	15	15.26	15.56
Total Common Shares Outstanding	15.83	14.68	14.5	15.05	15.33	15.7
Working Capital	-31.86	6.68	56.2	161.62	187.02	280.01
Book Value Per Share	11.68	14.61	17.35	23.31	25.27	29.28
Tangible Book Value	162.58	191.34	234.92	331.43	360.02	428.76
Tangible Book Value Per Share	10.27	13.03	16.20	22.02	23.48	27.31
Buildings	-	4.97	4.76	4.9	5.04	5.47
Construction In Progress	-	0	0.01	0.15	1.4	1.47
Leasehold Improvements	-	12.06	11.31	13.08	13.15	12.87

SEC Filings: 10-K · 10-Q